ZCARW
Get informed when a big investor buys or sells
+ FollowOvervalued by 2226.4% based on the discounted cash flow analysis.
| Market cap | $73,376.00 |
|---|---|
| Enterprise Value | $4.97 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-51.84 |
| Beta | 0.89 |
| Outstanding Shares | 12,237,383 |
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.0 |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 1.02 |
| Enterprise Value to EBIT | -3.56 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 1.04 |
| Debt to Equity | -0.19 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 0.13% |
|---|---|
| Total Invested | $13▼ 99.86% |
| Investors Holding | 1▼ 3.00% |
No data
we are a blank check firm, commonly referred to as a special purpose acquisition company with a primary focus on technology companies in the space of consumer tech, healthcare or technology services